产品名称 | NebuSelect™ Recombinant Human GIP, hFc-tag |
---|---|
目录号 | NBL-242581 |
别名 | GIP; GIP; Incretin |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P09681 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242581-100ug | 100ug | Inquire | Inquire | |
NBL-242581-1mg | 1mg | Inquire | Inquire | |
NBL-242581-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human GIP, hFc-tag
Catalog#:
NBL-242581
Description:
NebuSelect™ Recombinant Human GIP, hFc-tag(Cat#NBL-242581) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Glu22-Gln93.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 34.9 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Bis-Tris PAGE result.
Target Name:
GIP; GIP; Incretin
Target Information:
The potential application of glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide, GIP) in the management of obesity and type 2 diabetes has been controversial. Initial interest in the therapeutic use of GIP was dampened by evidence that its insulinotropic activity was reduced in type 2 diabetes and by reports that it increased glucagon secretion and adipose deposition in non-diabetic individuals.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.